Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of LCA-Vision, Inc. Stockholders
18 Fevereiro 2014 - 7:36PM
Business Wire
Kirby McInerney LLP is investigating potential claims against
the Board of Directors of LCA-Vision, Inc. (“LCA-Vision” or the
“Company”) (NASDAQ:LCAV) concerning the proposed acquisition of the
Company by PhotoMedex, Inc. (“PhotoMedex”) (NASDAQ: PHMP). Under
the terms of the definitive merger agreement, LCA-Vision
stockholders will receive $5.37 in cash for each share of
LCA-Vision owned, valuing the transaction at approximately $106.4
million.
The investigation concerns whether the LCA-Vision Board of
Directors violated its fiduciary duties by agreeing to the proposed
transaction and whether the proposed consideration adequately
values LCA-Vision’s common stock.
If you are an LCA-Vision stockholder and wish to obtain
additional information, please contact J. Brandon Walker, Esq.
by email at bwalker@kmllp.com, by telephone at (212) 699-1145 or
(888) 529-4787, or by filling out this contact form. There is no
cost or obligation to you.
Kirby McInerney LLP is a New York-based law firm concentrating
in securities, shareholder, whistleblower, antitrust and consumer
litigation. For additional information, please go to
www.kmllp.com.
Kirby McInerney LLPJ. Brandon Walker, Esq., (212) 699-1145
or (888) 529-4787bwalker@kmllp.com
(MM) (NASDAQ:LCAV)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
(MM) (NASDAQ:LCAV)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024
Notícias em tempo-real sobre (MM) da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Lca-Vision Inc. (MM)